Anelixis Therapeutics, LLC
2 clinical trials · Sponsor
◉ Watch Anelixis Therapeutics, LLC
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability and Efficacy of Immunomodulation With AT-1501 in Islet Cell Transplantation (NCT04711226) | Anelixis Therapeutics, LLC | 2021-02-19 |
| Multiple Doses of AT-1501-A201 in Adults With ALS (NCT04322149) | Anelixis Therapeutics, LLC | 2020-10-16 |
Track Anelixis Therapeutics, LLC automatically
Every clearance here is in the API, with alerts when new ones post.